RAPT Therapeutics Appoints Rodney Young as Chief Financial Officer

4 Dec 2019 - Yahoo News
RAPT Therapeutics, Inc. (RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced the appointment of Rodney Young ...
usx:rapt

---

RAPT Therapeutics and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia

3 Dec 2019 - Yahoo News
RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, and Hanmi Pharmaceutical Co., LTD today ...
usx:rapt

---

RAPT Therapeutics Announces Pricing of Initial Public Offering

31 Oct 2019 - Yahoo News
RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced the pricing of its ...
usx:rapt

---

Rapt Therapeutics IPO: What You Need To Know

30 Jul 2019 - Yahoo News
The IPO calendar this week has a single biotech issue which has in its clinical pipeline, product candidates targeting oncology and inflammatory diseases. The IPO Terms San Francisco, California-based ...
usx:rapt

---

Rapt Therapeutics files for initial public offering

5 Jul 2019 - Yahoo News
Rapt Therapeutics Inc. late Friday said it plans to go public, according to a filing with the Securities and Exchange Commission. The South San Francisco, Calif.-based biotech company, formerly known as FLX Bio Inc., said it plans to raise up to $86.3 million in the offering to finance clinical trials ...
usx:rapt

---